← All trials
NCT04988048
Phase 2Interventional
Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 3, 2021
- Primary completion
- Sep 30, 2021
- Completion date
- Feb 15, 2022
- First posted
- Aug 3, 2021
- Last posted
- Sep 29, 2021
- Enrollment
- 1760
- Arms / groups
- 14 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Government of ArgentinaLead sponsor
- Government of ArgentinaReponsible party - principal investigator
- Government of ArgentinaOverall official - principal investigator
- Government of RussiaCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.